ELIMINATION OF CD19-POSITIVE LYMPHOID MALIGNANCIES BY CD19-CAR EXPRESSING NK CELLS
- 专利权人:
- INC.;NANTKWEST
- 发明人:
- Hans G. Klingemann,Laurent H. Boissel,Patrick Soon-Shiong
- 申请号：
- US16529251
- 公开号：
- US20200129553A1
- 申请日:
- 2019.08.01
- 申请国别(地区):
- US
- 年份:
- 2020
- 代理人:
- 摘要：
- Provided herein are compositions of NK-92® cells that express a CD19 CAR, CD16 and IL2, and the method of using these cells to and treat cancer in a patient.
- 来源网站：
- 中国工程科技知识中心
